Several studies have demonstrated that numerous genes with deregulated methylation status, such as KRAS, CDKN2A, TP53, CD1D, MUC4, and MUC1 play vital roles in the progression of pancreatic cancer (6–8). This evidence concerns the gene TP53 and pancreatic neoplasm.